[{"id":"cd31500e-6fc2-462e-ae45-6974a2bb837f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04609241","created_at":"2021-01-19T20:32:05.435Z","updated_at":"2024-07-02T16:36:39.407Z","phase":"Phase 1","brief_title":"CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma","source_id_and_acronym":"NCT04609241","lead_sponsor":"Zhejiang University","biomarkers":" CD79B • IL3RA","pipe":"","alterations":" ","tags":["CD79B • IL3RA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD79b CAR-T cell therapy"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 72","initiation":"Initiation: 11/15/2020","start_date":" 11/15/2020","primary_txt":" Primary completion: 11/15/2023","primary_completion_date":" 11/15/2023","study_txt":" Completion: 11/15/2026","study_completion_date":" 11/15/2026","last_update_posted":"2020-10-30"}]